Literature DB >> 17988845

EMILINs interact with anthrax protective antigen and inhibit toxin action in vitro.

Roberto Doliana1, Veljko Veljkovic, Jelena Prljic, Nevena Veljkovic, Elisa De Lorenzo, Maurizio Mongiat, Giovanni Ligresti, Stefano Marastoni, Alfonso Colombatti.   

Abstract

The informational spectrum method (ISM) is a virtual spectroscopy method for the fast analysis of potential protein-protein relationships. By applying the ISM approach to the GeneBank protein database the vascular proteins EMILIN1 (Elastin Microfibril Interface Located ProteIN), EMILIN2, MMN1, and MMN2 were identified as additional anthrax PA antigen interacting molecules. This virtual molecular interaction was formally proven by solid phase assays using recombinant proteins. The interaction is independent of the presence of divalent cations and does not involve PA aspartic residue at 683, a critical residue in receptor binding. In fact, the D683A point mutation fully prevented the cell intoxication ability of PA in the presence of Lethal Factor, but it was fully ineffective on the binding of mutated PA to EMILIN1 and EMILIN2. The ISM approach also led to the identification of the potential interaction sites between PA and EMILINs. A PA mutant with a deletion at residue D425 and solid phase protein-protein interaction studies as well as deletion mutant of EMILIN2 confirmed the hypothesized interaction site. Our findings imply that the PA-cell surface receptor interaction is not likely to provide the full explanation for the vascular lesions and prominent hemorrhages that follow Bacillus anthracis infection and spreading and call into play vascular associated proteins such as EMILINs as potential inhibitory proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17988845     DOI: 10.1016/j.matbio.2007.09.008

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  9 in total

1.  Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice.

Authors:  Adrianus C M Boon; Jennifer deBeauchamp; Anna Hollmann; Jennifer Luke; Malak Kotb; Sarah Rowe; David Finkelstein; Geoffrey Neale; Lu Lu; Robert W Williams; Richard J Webby
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

2.  The ablation of the matricellular protein EMILIN2 causes defective vascularization due to impaired EGFR-dependent IL-8 production affecting tumor growth.

Authors:  Alice Paulitti; Eva Andreuzzi; Dario Bizzotto; Rosanna Pellicani; Giulia Tarticchio; Stefano Marastoni; Chiara Pastrello; Igor Jurisica; Giovanni Ligresti; Francesco Bucciotti; Roberto Doliana; Roberta Colladel; Paola Braghetta; Evelina Poletto; Alessia Di Silvestre; Giorgio Bressan; Alfonso Colombatti; Paolo Bonaldo; Maurizio Mongiat
Journal:  Oncogene       Date:  2018-02-27       Impact factor: 9.867

3.  In silico analysis suggests interaction between Ebola virus and the extracellular matrix.

Authors:  Veljko Veljkovic; Sanja Glisic; Claude P Muller; Matthew Scotch; Donald R Branch; Vladimir R Perovic; Milan Sencanski; Nevena Veljkovic; Alfonso Colombatti
Journal:  Front Microbiol       Date:  2015-02-19       Impact factor: 5.640

4.  Demonstration of a direct interaction between β2-adrenergic receptor and insulin receptor by BRET and bioinformatics.

Authors:  Maja Mandić; Luka Drinovec; Sanja Glisic; Nevena Veljkovic; Jane Nøhr; Milka Vrecl
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

5.  The EMILIN/Multimerin family.

Authors:  Alfonso Colombatti; Paola Spessotto; Roberto Doliana; Maurizio Mongiat; Giorgio Maria Bressan; Gennaro Esposito
Journal:  Front Immunol       Date:  2012-01-06       Impact factor: 7.561

6.  Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: possible consequences for therapy and infection control.

Authors:  Veljko Veljkovic; Nevena Veljkovic; Claude P Muller; Sybille Müller; Sanja Glisic; Vladimir Perovic; Heinz Köhler
Journal:  BMC Struct Biol       Date:  2009-04-07

7.  In silico Therapeutics for Neurogenic Hypertension and Vasovagal Syncope.

Authors:  Tijana Bojić; Vladimir R Perović; Sanja Glišić
Journal:  Front Neurosci       Date:  2016-01-21       Impact factor: 4.677

8.  Editorial: Neurocardiovascular Diseases: New Aspects of the Old Issues.

Authors:  Tijana Bojić
Journal:  Front Neurosci       Date:  2019-01-11       Impact factor: 4.677

9.  Computational design and characterization of nanobody-derived peptides that stabilize the active conformation of the β2-adrenergic receptor (β2-AR).

Authors:  Milan Sencanski; Sanja Glisic; Marko Šnajder; Nevena Veljkovic; Nataša Poklar Ulrih; Janez Mavri; Milka Vrecl
Journal:  Sci Rep       Date:  2019-11-12       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.